Skip to main content
RIGL logo
RIGL
(NASDAQ)
Rigel Pharmaceuticals, Inc.
$40.17-- (--)
Loading... - Market loading

Rigel Pharmaceuticals (RIGL) Stock Price & Financial Analysis

Rigel Pharmaceuticals Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$39.51 - $41.13
52-Week High$52.24
52-Week Low$24.95
Open$39.55
Volume315.50K
Average Volume (3M)372.10K
Market Cap790.79M
Shares Outstanding19.69M
P/E Ratio (TTM)2.17
Forward P/E1.05
Price to Sales (P/S)2.64
Price to Book (P/B)1.98
EV/EBITDA6.19
Revenue (TTM)299.77M
Net Income (TTM)364.23M
Free Cash Flow (TTM)79.27M
EPS (TTM)$19.21
Profit Margin121.51%
Operating Margin41.56%
Return on Equity (ROE)91.08%
Debt to Equity0.11
50-Day MA$36.65
200-Day MA$35.25
52-Week Change31.96%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About Rigel Pharmaceuticals

What is the current stock price for RIGL?

As of the latest trading session, RIGL stock trades at $40.17. The 52-week range is $24.95–$52.24, with a day range of $39.51–$41.13.

What is the P/E ratio for RIGL?

Rigel Pharmaceuticals's trailing P/E ratio is 2.2, meaning investors pay $2.2 for every $1 of annual earnings. The forward P/E is 1.1, reflecting analyst expectations for future earnings. Rigel Pharmaceuticals operates in the Healthcare sector.

Does RIGL pay dividends?

Rigel Pharmaceuticals does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for RIGL?

Based on 1 analyst, the consensus for RIGL is Buy.

What is the market cap of RIGL?

Rigel Pharmaceuticals's market capitalization is $790.8M, classifying it as a small-cap company. Rigel Pharmaceuticals operates in the Healthcare sector within the Biotechnology industry.